주요메뉴 바로가기 본문 바로가기

주메뉴

IBS Conferences

Regulating the Immune System's 'Regulator'

- Immune cells that curb over-reacting immune responses need Foxp1 protein -

A research team at the Academy of Immunology and Microbiology, within the Institute for Basic Science (IBS) has discovered a possible therapeutic target that pulls the reins of immunity. On Nature Communications, the scientists reported that mice lacking Foxp1 protein in some specific immune cells are more susceptible to immune-induced inflammation.

The immune system is capable of protecting the body from invading pathogens, but it can also over-react and cause allergies and autoimmunity. In this respect, regulatory T (Treg) cells are an important built-in "self-check" of the immune system: they put a break to other cells, preventing excessive immune reactions from happening. Since their discovery, Treg cells have been studied extensively as compelling and multifaceted therapeutic supplement. For example, Treg cells could be valuable to block the unruly immune responses in autoimmune diseases, like Crohn's disease or inflammatory bowel disease. Vice versa, in the case of tumors, Treg cells would need to be restrained to let anti-tumor immune response act more freely.

In the past decade, it has been established that broadly speaking, two different types of Treg cells exist in mammals: thymic Treg (tTreg) and induced Treg (iTreg). tTreg cells are generated at a neonatal age in the thymus, and protect us from fatal autoimmune reactions. Whereas iTreg cells form later in life and accumulate predominantly at mucosal barriers, such as: intestine, lungs, etc. In the large intestine, iTreg cells are essential to prevent an overenthusiastic immune response to fight against useful gut bacteria and harmless food.

iTreg cells could be good candidates for therapeutic interventions. iTreg precursors, unlike tTreg cells, could potentially be isolated from the host, modified, expanded in the laboratory, and subsequently transferred back to the host. Researchers are, however, facing problems with iTreg's stability: once generated, these cells tend to lose their regulatory identity and convert to other cell types. "It is necessary to find out molecules that control the fate of iTreg cells," says IBS researcher and the first author of the study, Sayantani Ghosh.

In this study, IBS researchers found that Foxp1 provides stability to iTreg cells, by interacting with the gene encoding its "sibling": Foxp3 – the protein that confers identity to Treg cells. iTreg cells lacking Foxp1 gradually lose Foxp3, and become unable to perform their regulatory functions against excessive immunity. In mice, the lack of Foxp1 in iTreg cells led to intestinal inflammation and increased susceptibility to colitis.

Moreover, IBS biologists showed that Foxp1 is essential for sustaining optimal expression of Foxp3 specifically in iTreg cells, not in tTreg cells. "In a venture to spot differences hidden behind cells with similar appearances, we found Foxp1. The results suggest that this protein could be used to engineer more stable iTreg cells, while keeping their thymic counterparts untouched," explains Dipayan Rudra, corresponding author of the study.


Figure 1: Lack of Foxp1 leads to inflammation of the large intestine (colitis). (Left) In healthy conditions, iTreg cells (blue) with sufficient Foxp1 keep a check over other immune cells (T-cells, orange, green and purple) in the large intestine. (Right) If Foxp1 is absent, iTreg cells are dramatically reduced and therefore can't control the activity of other immune cells. As a consequence, T-cells over-react against harmless gut bacteria and food, causing irritation, inflammation, and leading to colitis and ulcer. (Modified from Brgfx - Freepik.com)
Figure 1: Lack of Foxp1 leads to inflammation of the large intestine (colitis). (Left) In healthy conditions, iTreg cells (blue) with sufficient Foxp1 keep a check over other immune cells (T-cells, orange, green and purple) in the large intestine. (Right) If Foxp1 is absent, iTreg cells are dramatically reduced and therefore can't control the activity of other immune cells. As a consequence, T-cells over-react against harmless gut bacteria and food, causing irritation, inflammation, and leading to colitis and ulcer. (Modified from Brgfx - Freepik.com)

Dipayan Rudra and Letizia Diamante

Notes for editors

- References
Sayantani Ghosh, Sinchita Roy-Chowdhuri, Keunsoo Kang, Sin-hyeog Im, Dipayan Rudra*. The transcription factor Foxp1 preserves integrity of an active Foxp3 locus in extrathymic Treg cells. Nature Communications (2018). DOI: 10.1038/s41467-018-07018-y

- Media Contact
For further information or to request media assistance, please contact: Mr. Kyungyoon Min, Head of Communications Team, Institute for Basic Science (IBS) (+82-42-878-8156, kymin@ibs.re.kr); or Ms. Carol Kim, Global Officer, Communications Team, IBS (+82-42-878-8133, clitie620@ibs.re.kr)

- About the Institute for Basic Science (IBS)
IBS was founded in 2011 by the government of the Republic of Korea with the sole purpose of driving forward the development of basic science in South Korea. IBS has launched 28 research centers as of November 2018. There are nine physics, one mathematics, six chemistry, eight life science, one earth science, and three interdisciplinary research centers.

Academy of Immunology and Microbiology

Publication Repository
임신혁
Im, Sin Hyeog 이메일 보내기 Academy of Immunology and Microbiology Publications
Dipayan Rudra
Rudra, Dipayan 이메일 보내기 Academy of Immunology and Microbiology Publications
  • [Eurekalert] Regulating the immune system's 'regulator'
  • Research

    Are you satisfied with the information on this page?

    Content Manager
    Communications Team : Baek Seo Yun   042-878-8238
    Last Update 2018-11-10 11:50